2008
DOI: 10.1016/j.ijantimicag.2008.01.032
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic analysis of miltefosine-resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A (eIF4A)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…Traditionally, one of the challenges faced by proteomics is attaining a significant detection threshold for changes in membrane-bound proteins that are difficult to resolve by mass spectrometry proteomics, since the technologies are biased toward soluble hydrophilic peptides (64). In fact, of the comparative proteomics studies addressing drug resistance (65)(66)(67)(68), only one stressed the importance of PgP (a membrane glycoprotein) expression as a beacon for HePC resistance, underscoring the importance of complementary omics to acquire the most comprehensive insight for multifaceted processes, such as HePC resistance. In this regard, other complementary proteomic approaches concerning the lines described in this study are in progress.…”
Section: Discussionmentioning
confidence: 99%
“…Traditionally, one of the challenges faced by proteomics is attaining a significant detection threshold for changes in membrane-bound proteins that are difficult to resolve by mass spectrometry proteomics, since the technologies are biased toward soluble hydrophilic peptides (64). In fact, of the comparative proteomics studies addressing drug resistance (65)(66)(67)(68), only one stressed the importance of PgP (a membrane glycoprotein) expression as a beacon for HePC resistance, underscoring the importance of complementary omics to acquire the most comprehensive insight for multifaceted processes, such as HePC resistance. In this regard, other complementary proteomic approaches concerning the lines described in this study are in progress.…”
Section: Discussionmentioning
confidence: 99%
“…Among the identified antigens associated with the post-VL subset, four of them (LieIF4A, LieEF1B, enolase and MAT2) have been reported as highly expressed in drug-resistant strains [12][14] and have been implicated in the survival of the parasite inside the host [15], [16]. For the six identified antigens that reacted with sera from the VL naturally resistant people (PDI, alpha- and beta-tubulin, vacuolar ATP synthase subunit B and HSP83), drug resistance implications and host parasite survival properties have been previously described too [13], [17]–[21].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, eIF4A inhibitors have been shown to act as dual-targeting therapeutic agents by interfering with both pathogen and host eIF4A activity during malaria, an infection caused by protozoan parasites of the genus Plasmodium [12]. Of note, a strain of L. donovani resistant to miltefosine had increased levels of eIF4A [63] and high-throughput screenings identified Leishmania eIF4A as a potential druggable target [64][65][66][67]. Collectively, our data along with previous studies warrant further investigation on the potential of targeting eIF4A-dependent host and parasite mRNA translation to treat L. donovani infections.…”
Section: Plos Pathogensmentioning
confidence: 99%